Skip to Content

Cancers, Volume 15, Issue 13

2023 July-1 - 270 articles

Cover Story: Myelofibrosis (MF) is an aggressive bone marrow cancer exhibiting heterogenous clinical manifestations and molecular profiles. Two distinct phenotypes—myeloproliferative and myelodepletive/cytopenic—exist at the two ends of the spectrum and are characterized by different degrees of cytopenias, splenomegaly, fibrosis, JAK2 V617F VAF and genomic complexity, resulting in vastly different prognoses and outcomes. Recognition of these diverse clinical phenotypes, their different underlying biology and the quest to address unique unmet needs in cytopenic MF fueled the development of non-myelosuppressive JAK inhibitors with anemia benefits (pacritinib, momelotinib). Expanded therapeutic options and the ability to tailor therapy may optimize outcomes and prolong survival across the disease spectrum. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (270)

  • Article
  • Open Access
4 Citations
2,659 Views
10 Pages

Distal Humeral Replacement in Patients with Primary Bone Sarcoma: The Functional Outcome and Return to Sports

  • Kristian Nikolaus Schneider,
  • Moritz Ellerbrock,
  • Georg Gosheger,
  • Lucia Maria Westphal,
  • Niklas Deventer,
  • Sebastian Klingebiel,
  • Carolin Rickert and
  • Christoph Theil

7 July 2023

Distal humeral replacement (DHR) is a limb-salvage option for the endoprosthetic reconstruction of bone defects following the resection of a primary bone sarcoma. As primary bone sarcomas are only occasionally located around the distal humerus, there...

(This article belongs to the Special Issue Advances in Bone Tumor and Sarcoma)
  • Article
  • Open Access
4 Citations
2,329 Views
12 Pages

Divergent Oxidative Stress in Normal Tissues and Inflammatory Cells in Hodgkin and Non-Hodgkin Lymphoma

  • Cecilia Marini,
  • Vanessa Cossu,
  • Francesco Lanfranchi,
  • Sonia Carta,
  • Francesca Vitale,
  • Francesca D’Amico,
  • Matteo Bauckneht,
  • Silvia Morbelli,
  • Maria Isabella Donegani and
  • Gianmario Sambuceti
  • + 12 authors

7 July 2023

Background: Previous studies reported mitochondrial and endoplasmic reticulum redox stress in peripheral blood mononucleated cells (PBMCs) of treatment-naïve Hodgkin lymphoma (HL) patients. Here, we assessed whether this response also applies to...

(This article belongs to the Special Issue Hematologic Malignancies: Challenges from Diagnosis to Treatment)
  • Article
  • Open Access
8 Citations
4,052 Views
17 Pages

Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors

  • Mathieu Chicard,
  • Yasmine Iddir,
  • Julien Masliah Planchon,
  • Valérie Combaret,
  • Valéry Attignon,
  • Alexandra Saint-Charles,
  • Didier Frappaz,
  • Cécile Faure-Conter,
  • Kévin Beccaria and
  • Gudrun Schleiermacher
  • + 9 authors

7 July 2023

Background: Liquid biopsies are revolutionary tools used to detect tumor-specific genetic alterations in body fluids, including the use of cell-free DNA (cfDNA) for molecular diagnosis in cancer patients. In brain tumors, cerebrospinal fluid (CSF) cf...

(This article belongs to the Topic Biomarker Development and Application)
  • Article
  • Open Access
2 Citations
3,164 Views
12 Pages

What Is the Significance of Indeterminate Pulmonary Nodules in High-Grade Soft Tissue Sarcomas? A Retrospective Cohort Study

  • Marcus J. Brookes,
  • Corey D. Chan,
  • Timothy P. Crowley,
  • Maniram Ragbir,
  • Thomas Beckingsale,
  • Kanishka M. Ghosh and
  • Kenneth S. Rankin

7 July 2023

Background: Sarcomas are rare, aggressive cancers which frequently metastasise to the lungs. Following diagnosis, patients typically undergo staging by means of a CT scan of their chest. This often identifies indeterminate pulmonary nodules (IPNs), b...

(This article belongs to the Special Issue Advances in Soft Tissue and Bone Sarcoma)
  • Article
  • Open Access
5 Citations
4,249 Views
24 Pages

B7-H3 Associates with IMPDH2 and Regulates Cancer Cell Survival

  • Salwa Alhamad,
  • Yassmin Elmasry,
  • Isabel Uwagboe,
  • Elena Chekmeneva,
  • Caroline Sands,
  • Benjamin W. Cooper,
  • Stephane Camuzeaux,
  • Ash Salam and
  • Maddy Parsons

7 July 2023

Lung cancer is one of the most common cancers worldwide, and despite improvements in treatment regimens, patient prognosis remains poor. Lung adenocarcinomas develop from the lung epithelia and understanding how specific genetic and environmental fac...

(This article belongs to the Topic Cancer Cell Metabolism)
  • Article
  • Open Access
19 Citations
3,404 Views
12 Pages

Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life Analysis

  • Eleni Gavriilaki,
  • Panagiotis Dolgyras,
  • Sotiria Dimou-Mpesikli,
  • Aikaterini Poulopoulou,
  • Paschalis Evangelidis,
  • Nikolaos Evangelidis,
  • Christos Demosthenous,
  • Evangelia Zachrou,
  • Panagiotis Siasios and
  • Ioanna Sakellari
  • + 11 authors

7 July 2023

(1) Background: Autologous, allogeneic hematopoietic cell transplantation (HCT) and other cellular therapies, including CAR T cell and gene therapy, constitute a cornerstone in the management of various benign and malignant hematological disorders. I...

(This article belongs to the Special Issue Hematologic Malignancies: Challenges from Diagnosis to Treatment)
  • Article
  • Open Access
6 Citations
3,365 Views
14 Pages

7 July 2023

Background: The detection of the EGFR T790M (T790M) mutation in non-small cell lung cancer (NSCLC) patients who progressed under treatment with first- or second-generation EGFR-tyrosine kinase inhibitors (TKIs) is important to offer a subsequent ther...

(This article belongs to the Section Cancer Metastasis)
  • Article
  • Open Access
10 Citations
3,323 Views
13 Pages

7 July 2023

Background: Non-overlapping somatic mutations in BRAF, NRAS, or NF1 genes occur in 85% of metastatic melanoma patients. It is not known whether these mutations affect immunotherapy outcome. Materials and methods: Next-Gen sequencing of 324 oncogenes...

(This article belongs to the Special Issue Epidemiology and Biological Features of Melanoma)
  • Review
  • Open Access
10 Citations
4,396 Views
12 Pages

Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach

  • Zohaib Sherwani,
  • Shreel Parikh,
  • Nikhil Yegya-Raman,
  • Kelly McKenna,
  • Matthew Deek,
  • Salma Jabbour and
  • Lara Hathout

7 July 2023

Historically, the role of radiation in gynecological metastatic disease involved palliation for pain or bleeding. Stereotactic Body Radiation Therapy (SBRT) has shown survival benefits in oligometastatic disease from varying primary histologies in re...

(This article belongs to the Special Issue Oligometastatic Disease)
  • Article
  • Open Access
3 Citations
3,011 Views
11 Pages

Dissecting the Methylomes of EGFR-Amplified Glioblastoma Reveals Altered DNA Replication and Packaging, and Chromatin and Gene Silencing Pathways

  • Theo F. J. Kraus,
  • Celina K. Langwieder,
  • Dorothee Hölzl,
  • Georg Hutarew,
  • Hans U. Schlicker,
  • Beate Alinger-Scharinger,
  • Christoph Schwartz and
  • Karl Sotlar

7 July 2023

Glioblastoma IDH wildtype is the most frequent brain tumor in adults. It shows a highly malignant behavior and devastating outcomes. To date, there is still no targeted therapy available; thus, patients’ median survival is limited to 12–1...

(This article belongs to the Section Cancer Pathophysiology)
  • Article
  • Open Access
3 Citations
3,004 Views
11 Pages

Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical Trial

  • Anuradha G. Trivedi,
  • Karthik K. Ramesh,
  • Vicki Huang,
  • Eric A. Mellon,
  • Peter B. Barker,
  • Lawrence R. Kleinberg,
  • Brent D. Weinberg,
  • Hui-Kuo G. Shu and
  • Hyunsuk Shim

7 July 2023

Despite aggressive treatment, glioblastoma has a poor prognosis due to its infiltrative nature. Spectroscopic MRI-measured brain metabolites, particularly the choline to N-acetylaspartate ratio (Cho/NAA), better characterizes the extent of tumor infi...

(This article belongs to the Special Issue Advanced Imaging in Brain Tumor Patient Management)
  • Review
  • Open Access
15 Citations
3,673 Views
14 Pages

Clinical Decision Support Systems for Brain Tumour Diagnosis and Prognosis: A Systematic Review

  • Teesta Mukherjee,
  • Omid Pournik,
  • Sarah N. Lim Choi Keung and
  • Theodoros N. Arvanitis

6 July 2023

CDSSs are being continuously developed and integrated into routine clinical practice as they assist clinicians and radiologists in dealing with an enormous amount of medical data, reduce clinical errors, and improve diagnostic capabilities. They assi...

(This article belongs to the Special Issue Decision-Support Systems for Cancer Diagnosis and Prognosis)
  • Article
  • Open Access
3 Citations
3,698 Views
15 Pages

Diagnostic Potential of Endometrial Cancer DNA from Pipelle, Pap-Brush, and Swab Sampling

  • Yinan Wang,
  • Hui Du,
  • Wenkui Dai,
  • Cuijun Bao,
  • Xi Zhang,
  • Yan Hu,
  • Zhiyu Xie,
  • Xin Zhao,
  • Changzhong Li and
  • Ruifang Wu
  • + 1 author

6 July 2023

Endometrial cancer (EC) is a major gynecological malignancy with rising morbidity and mortality worldwide. The aim of this study was to explore a safe and readily available sample and a sensitive and effective detection method and its biomarkers for...

(This article belongs to the Special Issue Gynecologic Cancer: From Diagnosis to Treatment)
  • Editorial
  • Open Access
2 Citations
1,613 Views
4 Pages

6 July 2023

After the initial reports of laparoscopic liver resection (LLR) in the early 1990s, minimally invasive liver resection has been rapidly developing based on technical and instrumental improvements [...]

(This article belongs to the Special Issue Advances in Minimally Invasive Liver Resection for Cancer Therapies)
  • Article
  • Open Access
16 Citations
7,498 Views
15 Pages

Breast Lesions of Uncertain Malignant Potential (B3) and the Risk of Breast Cancer Development: A Long-Term Follow-Up Study

  • Chiara Bellini,
  • Jacopo Nori Cucchiari,
  • Federica Di Naro,
  • Diego De Benedetto,
  • Giulia Bicchierai,
  • Andrea Franconeri,
  • Irene Renda,
  • Simonetta Bianchi and
  • Tommaso Susini

6 July 2023

Breast lesions of uncertain malignant potential (B3) are frequently diagnosed in the era of breast cancer (BC) screening and their management is controversial. They are generally removed surgically, but some international organizations and guidelines...

(This article belongs to the Special Issue Breast Cancer Risk and Prevention)
  • Article
  • Open Access
6 Citations
3,708 Views
11 Pages

Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer

  • Angeliki Andrikopoulou,
  • Charalampos Theofanakis,
  • Christos Markellos,
  • Maria Kaparelou,
  • Konstantinos Koutsoukos,
  • Kleoniki Apostolidou,
  • Nikolaos Thomakos,
  • Dimitrios Haidopoulos,
  • Alexandros Rodolakis and
  • Michalis Liontos
  • + 2 authors

6 July 2023

Background: There is limited data on the optimal time interval between the last dose of neoadjuvant chemotherapy (NACT) and interval debulking surgery (IDS) in high-grade serous ovarian carcinoma (HGSC). Methods: We retrospectively identified patient...

(This article belongs to the Special Issue Gynecologic Cancer: From Diagnosis to Treatment)
  • Article
  • Open Access
9 Citations
2,653 Views
21 Pages

Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms

  • Agnes Bocian-Jastrzębska,
  • Anna Malczewska-Herman,
  • Violetta Rosiek and
  • Beata Kos-Kudła

6 July 2023

Data on the possible connection between circulating adipokines and PanNENs are limited. This novel study aimed to assess the serum levels of leptin and adiponectin and their ratio in patients with PanNENs and to evaluate the possible relationship bet...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Systematic Review
  • Open Access
19 Citations
4,418 Views
18 Pages

The Effect of Aspirin Use on Incident Hepatocellular Carcinoma—An Updated Systematic Review and Meta-Analysis

  • Jonathan Abdelmalak,
  • Natassia Tan,
  • Danny Con,
  • Guy Eslick,
  • Ammar Majeed,
  • William Kemp and
  • Stuart K. Roberts

6 July 2023

An increasing number of observational studies have described an association between aspirin use and a reduced risk of incident hepatocellular carcinoma. We performed this meta-analysis to provide a comprehensive and updated aggregate assessment of th...

(This article belongs to the Section Systematic Review or Meta-Analysis in Cancer Research)
  • Article
  • Open Access
3,509 Views
14 Pages

Enzalutamide Prior to Radium-223 Is Associated with Better Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Compared to Abiraterone—A Retrospective Study

  • Hao Xiang Chen,
  • Li-Hsien Tsai,
  • Chao-Hsiang Chang,
  • Hsi-Chin Wu,
  • Ching-Chan Lin,
  • Che-Hung Lin,
  • Chin-Chung Yeh,
  • Chi-Rei Yang,
  • Chi-Shun Lien and
  • Chi-Ping Huang
  • + 5 authors

6 July 2023

Metastatic castration-resistant prostate cancer (mCRPC) is a progressive stage of prostate cancer that often spreads to the bone. Radium-223, a bone-targeting radiopharmaceutical, has been shown to improve the overall survival in mCRPC in patients wi...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
4 Citations
3,245 Views
16 Pages

6 July 2023

Colorectal cancer (CRC) is the second most common cause of cancer-related mortality in the United States. Among newly diagnosed patients with CRC, 20% will present with metastatic disease and another 25% will develop metastases. The surgical resectio...

  • Article
  • Open Access
8 Citations
2,385 Views
12 Pages

Function in Cancer Patients: Disease and Clinical Determinants

  • Evelyn S. Qin,
  • Blair Richards and
  • Sean R. Smith

6 July 2023

Patients with cancer often experience changes in function during and after treatment but it is not clear what cancer types, and associated clinical factors, affect function. This study evaluated patient-reported functional impairments between specifi...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Review
  • Open Access
30 Citations
15,208 Views
27 Pages

Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors

  • Eleonora Boscaro,
  • Irene Urbino,
  • Federica Maria Catania,
  • Giulia Arrigo,
  • Carolina Secreto,
  • Matteo Olivi,
  • Stefano D’Ardia,
  • Chiara Frairia,
  • Valentina Giai and
  • Marco Cerrano
  • + 3 authors

6 July 2023

An accurate estimation of AML prognosis is complex since it depends on patient-related factors, AML manifestations at diagnosis, and disease genetics. Furthermore, the depth of response, evaluated using the level of MRD, has been established as a str...

(This article belongs to the Special Issue Acute Myeloid Leukemia: The Future Is Bright)
  • Review
  • Open Access
11 Citations
5,027 Views
13 Pages

Dilemmas in the Clinical Management of pT1 Colorectal Cancer

  • Diana Zaffalon,
  • Maria Daca-Alvarez,
  • Karmele Saez de Gordoa and
  • María Pellisé

6 July 2023

Implementation of population-based colorectal cancer screening programs has led to increases in the incidence of pT1 colorectal cancer. These incipient invasive cancers have a very good prognosis and can be treated locally, but more than half of thes...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
8 Citations
3,027 Views
14 Pages

Elevated Tumor Cell-Intrinsic STING Expression in Advanced Laryngeal Cancer

  • Jelena Viculin,
  • Marina Degoricija,
  • Katarina Vilović,
  • Ivana Gabela,
  • Lucija Franković,
  • Eduard Vrdoljak and
  • Jelena Korac-Prlic

5 July 2023

Laryngeal cancer is the second most common malignancy of the head and neck, worldwide. Immunotherapy targeting checkpoint inhibitors has been approved for the treatment of patients with recurrent or metastatic laryngeal cancer but has a relatively lo...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Review
  • Open Access
38 Citations
8,654 Views
23 Pages

Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition

  • Bianca Medici,
  • Beatrice Riccò,
  • Eugenia Caffari,
  • Silvia Zaniboni,
  • Massimiliano Salati,
  • Andrea Spallanzani,
  • Ingrid Garajovà,
  • Stefania Benatti,
  • Chiara Chiavelli and
  • Fabio Gelsomino
  • + 1 author

5 July 2023

Despite a recent overall decrease in colorectal cancer (CRC) incidence and mortality, there has been a significant rise in CRC diagnoses in young adults. Early onset colorectal cancer (EOCRC) is defined as CRC diagnosed before the age of 50. Possible...

(This article belongs to the Special Issue Metastatic Colorectal Cancer 2.0)
  • Review
  • Open Access
21 Citations
4,725 Views
14 Pages

5 July 2023

The burden of hepatocellular carcinoma (HCC) continues to pose a significant global health problem. Several systemic therapies have recently been shown to improve survival for patients with unresectable disease. However, evidence to support the use o...

(This article belongs to the Special Issue Selecting the Best Approach for Single and Multiple Liver Tumors)
  • Review
  • Open Access
17 Citations
6,154 Views
28 Pages

5 July 2023

Mounting evidence links the phenomenon of enhanced recruitment of tumor-associated macrophages towards cancer bulks to neoplastic growth, invasion, metastasis, immune escape, matrix remodeling, and therapeutic resistance. In the context of cancer pro...

(This article belongs to the Special Issue Tumor Microenvironment and Molecular Aberrations Convey Immune Evasion)
  • Review
  • Open Access
53 Citations
7,529 Views
31 Pages

5 July 2023

Cancer represents a significant and persistent global health burden, with its impact underscored by its prevalence and devastating consequences. Whereas numerous oncogenes could contribute to cancer development, a group of transcription factors (TFs)...

(This article belongs to the Special Issue Pleiotropic Pro-tumor Activities Regulated by Overexpressed Yin Yang 1 (YY1) in Human Cancers: Clinical Implications)
  • Article
  • Open Access
3 Citations
2,507 Views
9 Pages

Increasing Patient Safety and Treatment Quality by Using Intraoperative MRI for Organ-Preserving Tumor Resection and High-Dose Rate Brachytherapy in Children with Bladder/Prostate and Perianal Rhabdomyosarcoma

  • Andreas Schmidt,
  • Constantin Roder,
  • Franziska Eckert,
  • David Baumann,
  • Maximilian Niyazi,
  • Frank Fideler,
  • Ulrike Ernemann,
  • Marcos Tatagiba,
  • Jürgen Schäfer and
  • Benjamin Bender
  • + 4 authors

5 July 2023

In children with bladder/prostate (BP) and perianal rhabdomyosarcoma (RMS), we use a hybrid treatment concept for those suitable, combining organ-preserving tumor resection and high-dose rate brachytherapy (HDR-BT). This treatment concept has been sh...

(This article belongs to the Collection Urological Cancer 2023-2025)
  • Article
  • Open Access
3 Citations
2,553 Views
14 Pages

5 July 2023

Transcriptomic personalisation of radiation therapy has gained considerable interest in recent years. However, independent model testing on in vitro data has shown poor performance. In this work, we assess the reproducibility in clinical applications...

(This article belongs to the Special Issue Personalized Radiotherapy in Cancer Care)
  • Article
  • Open Access
10 Citations
2,350 Views
11 Pages

5 July 2023

Several studies have shown that head and neck cancer is associated with an increased risk of stroke incidence. However, investigations of the association between the two diseases based on a matching cohort dataset are still limited. Therefore, we ide...

  • Article
  • Open Access
5 Citations
2,382 Views
11 Pages

Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma

  • Bianca Varzaru,
  • Razvan A. Iacob,
  • Adina E. Croitoru,
  • Speranta M. Iacob,
  • Cristina E. Radu,
  • Stefania M. Dumitrescu and
  • Cristian Gheorghe

5 July 2023

Purpose: To assess the efficacy of FOLFIRINOX(FFX), gemcitabine-based regimens (GB), and gemcitabine monotherapy (Gem) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC). Methods: This is a retrospective study that included 83 patie...

(This article belongs to the Special Issue Management of Pancreatic Cancer)
  • Editorial
  • Open Access
5 Citations
1,805 Views
4 Pages

5 July 2023

In recent years, more attention has been directed to personalized medicine in the management and treatment of breast cancer (BC) [...]

(This article belongs to the Special Issue Breast Diseases; De-escalating Treatment: Current Status and Future Directions)
  • Article
  • Open Access
12 Citations
4,199 Views
20 Pages

5 July 2023

The tumor microenvironment (TME) in breast cancer is determined by the complex crosstalk of cancer cells with adipose tissue-inherent cells such as adipose-derived stromal cells (ASCs) and adipocytes resulting from the local invasion of tumor cells i...

(This article belongs to the Special Issue 3D Cell Culture Cancer Models: Development and Applications 2.0)
  • Review
  • Open Access
9 Citations
4,240 Views
18 Pages

5 July 2023

Immunotherapy is one of the leading systemic therapies in non-small cell cancer (NSCLC) patients, but it is not effective in an important proportion of them due to primary or secondary resistance mechanisms. Clinicians do not have the tools to predic...

(This article belongs to the Special Issue Advances in Cancer Immunotherapy)
  • Article
  • Open Access
8 Citations
2,624 Views
18 Pages

Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1

  • Enza Torre,
  • Giulia Pinton,
  • Grazia Lombardi and
  • Silvia Fallarini

5 July 2023

Invariant natural killer T (iNKT) cells are a distinct group of immune cells known for their immunoregulatory and cytotoxic activities, which are crucial in immune surveillance against tumors. They have been extensively investigated as a potential ta...

  • Article
  • Open Access
8 Citations
2,391 Views
9 Pages

Are CT-Derived Muscle Measurements Prognostic, Independent of Systemic Inflammation, in Good Performance Status Patients with Advanced Cancer?

  • Josh McGovern,
  • Ross D. Dolan,
  • Claribel Simmons,
  • Louise E. Daly,
  • Aoife M. Ryan,
  • Derek G. Power,
  • Marie T. Fallon,
  • Barry J. Laird and
  • Donald C. McMillan

5 July 2023

The present study examined the relationships between CT-derived muscle measurements, systemic inflammation, and survival in advanced cancer patients with good performance status (ECOG-PS 0/1). Data was collected prospectively from patients with advan...

(This article belongs to the Collection Cancer Biomarkers)
  • Article
  • Open Access
16 Citations
3,933 Views
16 Pages

Emotional, Behavioral, and Physical Health Consequences in Caregivers of Children with Cancer: A Network Analysis Differentiation in Mothers’ and Fathers’ Reactivity

  • Dorella Scarponi,
  • Pierfrancesco Sarti,
  • Veronica Rivi,
  • Chiara Colliva,
  • Elisa Marconi,
  • Andrea Pession and
  • Johanna M. C. Blom

4 July 2023

Background: Pediatric cancer presents mental and physical challenges for patients and their caregivers. However, parental distress has been understudied despite its negative impact on quality of life, disability, and somatic disorders. Parents of onc...

(This article belongs to the Special Issue Parenting and Cancer)
  • Article
  • Open Access
5 Citations
2,303 Views
15 Pages

Prognostic Implication of YY1 and CP2c Expression in Patients with Primary Breast Cancer

  • Chihwan David Cha,
  • Seung Han Son,
  • Chul Geun Kim,
  • Hosub Park and
  • Min Sung Chung

4 July 2023

Yin Yang 1 (YY1) is a transcription factor that regulates epigenetic pathways and protein modifications. CP2c is a transcription factor that functions as an oncogene to regulate cell proliferation. YY1 is known to interact with CP2c to suppress CP2c&...

  • Perspective
  • Open Access
2 Citations
2,844 Views
13 Pages

4 July 2023

In endocrinology, endoscopic ultrasound (EUS) may be used to image the adrenals, the endocrine pancreas, and other organs where endocrine neoplasms may occur. During the recent decades, EUS has been established predominantly to assess multiple endocr...

(This article belongs to the Special Issue Pancreatic Neuroendocrine Tumors)
  • Review
  • Open Access
12 Citations
6,171 Views
23 Pages

Targeted Alpha Therapy (TAT) with Single-Domain Antibodies (Nanobodies)

  • Kate Hurley,
  • Meiyun Cao,
  • Haiming Huang and
  • Yi Wang

4 July 2023

The persistent threat of cancer necessitates the development of improved and more efficient therapeutic strategies that limit damage to healthy tissues. Targeted alpha therapy (TαT), a novel form of radioimmuno-therapy (RIT), utilizes a targeti...

(This article belongs to the Special Issue Cell Signaling in Cancer and Cancer Therapy)
  • Article
  • Open Access
5 Citations
7,413 Views
15 Pages

Incidence and Mortality of Malignant Brain Tumors after 20 Years of Mobile Use

  • Mohy Uddin,
  • Rozy Dhanta,
  • Thejkiran Pitti,
  • Diana Barsasella,
  • Jeremiah Scholl,
  • Wen-Shan Jian,
  • Yu-Chuan (Jack) Li,
  • Min-Huei Hsu and
  • Shabbir Syed-Abdul

4 July 2023

(1) Objective: This population-based study was performed to examine the trends of incidence and deaths due to malignant neoplasm of the brain (MNB) in association with mobile phone usage for a period of 20 years (January 2000–December 2019) in...

(This article belongs to the Section Tumor Microenvironment)
  • Systematic Review
  • Open Access
29 Citations
6,178 Views
20 Pages

The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge—A Systematic Review

  • Adrian Perdyan,
  • Bartosz Kamil Sobocki,
  • Amar Balihodzic,
  • Anna Dąbrowska,
  • Justyna Kacperczyk and
  • Jacek Rutkowski

4 July 2023

Despite a great success of immunotherapy in cancer treatment, a great number of patients will become resistant. This review summarizes recent reports on immune checkpoint inhibitor retreatment or rechallenge in order to overcome primary resistance. T...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
11 Citations
5,182 Views
23 Pages

Understanding WT1 Alterations and Expression Profiles in Hematological Malignancies

  • Naghmeh Niktoreh,
  • Lisa Weber,
  • Christiane Walter,
  • Mahshad Karimifard,
  • Lina Marie Hoffmeister,
  • Hannah Breiter,
  • Aniththa Thivakaran,
  • Maren Soldierer,
  • Hans Günther Drexler and
  • Helmut Hanenberg
  • + 4 authors

4 July 2023

WT1 is a true chameleon, both acting as an oncogene and tumor suppressor. As its exact role in leukemogenesis is still ambiguous, research with model systems representing natural conditions surrounding the genetic alterations in WT1 is necessary. In...

(This article belongs to the Special Issue Recent Advances in the Understanding of Myelodysplastic Syndrome and Acute Myeloid Leukemia)
  • Article
  • Open Access
9 Citations
3,482 Views
12 Pages

GALNT1 Expression Is Associated with Angiogenesis and Is a Prognostic Biomarker for Breast Cancer in Adolescents and Young Adults (AYA)

  • Masanori Oshi,
  • Danya Ziazadeh,
  • Rongrong Wu,
  • Kohei Chida,
  • Akimitsu Yamada,
  • Shinya Yamamoto,
  • Kazutaka Narui,
  • Li Yan,
  • Takashi Ishikawa and
  • Kazuaki Takabe
  • + 1 author

4 July 2023

It is well established that genetic information differs amongst the adolescent and young adult population (AYA) and older patients. Although several studies on genetic information have been conducted, no current prognostic biomarker exists to help di...

(This article belongs to the Special Issue Tumor Microenvironment of Breast Cancer)
  • Editorial
  • Open Access
1 Citations
1,728 Views
6 Pages

4 July 2023

Cancer initiation, growth, and progression are sustained by multiple types of genetic alterations, ranging in size from single point mutations, focal genomic errors to broad chromosomal copy number alterations, gains, and losses [...]

(This article belongs to the Special Issue Inside Cancer Genomics: From Structure to Therapy)
  • Article
  • Open Access
3 Citations
2,689 Views
11 Pages

‘Stealth’ Prostate Tumors

  • Vinayak G. Wagaskar,
  • Osama Zaytoun,
  • Swati Bhardwaj and
  • Ash Tewari

4 July 2023

Background: The aim of this study was to determine the false negative rates of prebiopsy magnetic resonance imaging (MRI) and MRI–ultrasound (US) 12-core systematic prostate biopsy (PBx) by analyzing radical prostatectomy specimens. Methods: Th...

(This article belongs to the Topic Prostate Cancer: Symptoms, Diagnosis & Treatment - 2nd Volume)
  • Review
  • Open Access
9 Citations
3,793 Views
15 Pages

4 July 2023

Pancreatic adenocarcinoma is a highly aggressive disease with a poor prognosis. The reprogramming of energetic metabolism has long been implicated in pancreatic tumorigenesis and/or resistance to treatment. Considering that long non-coding RNA dysreg...

(This article belongs to the Special Issue Molecular Genetics of Pancreatic Cancer and Translational Challenges)
  • Systematic Review
  • Open Access
13 Citations
3,979 Views
19 Pages

Understanding Sleep Disturbances in Prostate Cancer—A Scientometric Analysis of Sleep Assessment, Aetiology, and Its Impact on Quality of Life

  • Stephen Mangar,
  • Monica Abbadasari,
  • Alessandro Carollo,
  • Gianluca Esposito,
  • Hashim Ahmed,
  • Taimur Shah and
  • Dagmara Dimitriou

4 July 2023

Prostate cancer is the most commonly diagnosed cancer in the United Kingdom. While androgen-deprivation therapy is the most common treatment for prostate cancer, patients undergoing this treatment typically experience side effects in terms of sleep d...

of 6

XFacebookLinkedIn
Cancers - ISSN 2072-6694